Market News Archives

Game Changer for Immunocompromised? GeoVax Makes Case at World Vaccine Congress Europe 2025 -( $GOVX $IBB $XBI )

by Vista Partners LLC October 9, 2025 687Views 0Likes

GeoVax Labs (NASDAQ: GOVX) is advancing its multi-antigen COVID-19 vaccine, GEO-CM04S1, with fresh clinical data set to take center stage at the World Vaccine Congress Europe 2025, Europe's largest vaccine event, held October 13-16 at the RAI Amsterdam Convention Centre in…

Novo Nordisk’s $5.2 Billion Bet on Liver Disease: Why Akero’s Efruxifermin May Be The Next Obesity-Linked Blockbuster -( $NVO $AKRO $RHHBY $IBB $XBI )

by Vista Partners LLC October 9, 2025 550Views 0Likes

In a move signaling Novo Nordisk’s (NVO) sharpened ambitions beyond diabetes and obesity, the Danish pharmaceutical giant announced on Thursday its intent to acquire Akero Therapeutics (AKRO) for as much as $5.2 billion, vaulting itself into the late-stage metabolic liver disease race.…

Portugal’s 40-Year Old Cristiano Ronaldo Becomes Football’s First Billionaire Player After Al Nassr Mega-Deal

by Vista Partners LLC October 8, 2025 654Views 0Likes

Cristiano Ronaldo, one of the most decorated athletes in modern sports, has become football’s first player to reach billionaire status, according to data compiled by the Bloomberg Billionaires Index. The Portuguese star’s net worth has been estimated at roughly $1.4 billion, fueled by…

Inside Serina’s $20 Million Financing Push: A New Approach for Advanced Parkinson’s Disease -( $SER $IBB $XBI )

by Vista Partners LLC October 8, 2025 627Views 0Likes

Serina Therapeutics (NYSE American: SER) stands at a pivotal juncture as it harnesses fresh capital, regulatory momentum, and a sharpened communications strategy to propel its lead program, SER-252, into late-stage clinical testing for advanced Parkinson’s disease. The Alabama-based biotech is betting its…

“Buckle Up”: IMF Flags Mounting Uncertainty for Investors in 2025 As Gold Flys Higher -( $SPY $QQQ $DIA $GLD )

by Vista Partners LLC October 8, 2025 512Views 0Likes

The global economy, fortified by surprising resilience, now faces a future marked by persistent caution and lurking risks, warns International Monetary Fund Managing Director Kristalina Georgieva. Speaking at a major Washington forum ahead of the IMF’s annual meetings, Georgieva noted that recession…

Tesla Slashes Prices: Model Y and Model 3 Standard Variants Target EV Market Recovery -( $TSLA $SPY )

by Vista Partners LLC October 7, 2025 577Views 0Likes

Tesla (TSLA) has launched new “Standard” versions of its Model 3 sedan and Model Y SUV, aiming to recapture momentum after a year marked by sluggish sales and growing competition in the electric vehicle market. The refreshed lineup is expected to appeal…

Modular Medical Appoints Insulin Pump Veteran, Eyes Aggressive Global Rollout for Pivot Device – ( $MODD $PODD )

by Vista Partners LLC October 7, 2025 619Views 0Likes

Modular Medical (NASDAQ: MODD) is entering a transformational phase with the appointment of David Bosshard as Head of International Operations, marking the company’s most ambitious push toward global expansion and market leadership in diabetes care technology. Bosshard’s proven expertise in scaling European…

Central Banks Fuel Gold’s Record Run—Can the $4,000 Barrier Hold? – ( $GLD $GS $JPM $SPY )

by Vista Partners LLC October 6, 2025 597Views 0Likes

Gold’s relentless rally has nudged the precious metal to the brink of $4,000 per ounce, carving out its biggest annual advance since 1979 amid political upheaval and a sharply deteriorating macroeconomic outlook. With the US government mired in a prolonged shutdown and…

AMD Shares Skyrocket After Securing Landmark GPU Supply Agreement With OpenAI – ( $AMD $NVDA )

by Vista Partners LLC October 6, 2025 668Views 0Likes

Advanced Micro Devices (NasdaqGS: AMD) soared on Monday after signing a blockbuster, multiyear supply agreement with OpenAI that could redefine the balance of power in the red-hot artificial intelligence chip market. Under the terms, OpenAI will purchase up to 6 gigawatts of…

Investing in Biotech’s Next Wave: Serina Therapeutics Blends Vision and Scientific Rigor – ( $SER $BHVN $IBB $XBI )

by Vista Partners LLC October 6, 2025 535Views 0Likes

Serina Therapeutics (NYSE American: SER), a clinical-stage biotechnology company developing its proprietary POZ Platform™ drug optimization technology, is scripting an uncommon chapter in biotech, bringing together seasoned leadership, investor-grade science, and strategic capital to tackle the field’s toughest clinical problems—all at a…

Market News

Your Guide To Staying Informed In The Markets